Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details Narrative) $ in Thousands	Mar. 31, 2024 USD ($)
Domestic Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 116,600
Research credit carryforwards	1,006
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	43,200
Foreign Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	1,800
California Research And Development [Member]
Operating Loss Carryforwards [Line Items]
Research credit carryforwards	$ 790